Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary ...
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
8don MSN
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...
Shatti, head of the Cardiac Catheterization Unit at Al-Dabous Center at Al-Adan Hospital, announced that the hospital has ...
Inquis Medical has raised $40 million in funding to support the development of its mechanical blood clot removal system. | ...
The Aventus thrombectomy system uses technology that tells the operator if the device’s tip is in contact with blood, a clot ...
Re-expansion pulmonary oedema (RPE) is an uncommon complication that occurs when a collapsed lung suddenly re-expands, resulting in an osmotic shift of fluid from the blood vessels into the air spaces ...
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback